10 completed, 1 terminated. 11 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 11 | Completed 10, Terminated 1 |
| Phase 3 | 2 | Completed 2 |
Follow Amyvid: new trials by email Literature Review of Amyvid trials Research Report on Amyvid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Tau Imaging of Chronic Traumatic Encephalopathy [F18]-T807, [F18]-Florbetapir, MRI/MRS - Chronic Traumatic Encephalopathy | Phase 2 | Completed | Brigham and Women's Hospital | 30 | 2015-01-01 | 2018-05-17 |
| 18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy florbetapir F 18, Flortaucipir F18 - Chronic Traumatic Encephalopathy | Phase 2 | Completed | Avid Radiopharmaceuticals | 41 | 2014-06-01 | 2020-09-07 |
| Imaging Characteristics of a Follow-up 18F-AV-1451 Scan Flortaucipir F18, Florbetapir F 18, Brain PET Scan - Alzheimer's Disease | Phase 2 | Terminated | Avid Radiopharmaceuticals | 44 | 2014-05-01 | 2020-09-07 |
| Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects florbetapir F 18, Flortaucipir F18, Brain PET Scan - Alzheimer's Disease | Phase 2 / Phase 3 | Completed | Avid Radiopharmaceuticals | 383 | 2013-12-01 | 2020-09-22 |
| A Phase II Trial of Florbetapir (18F) Positron Emission Tomography (PET) Imaging in Japan of Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) florbetapir (18F) - Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 / Phase 3 | Completed | Avid Radiopharmaceuticals | 48 | 2012-10-01 | 2013-09-19 |
| Clinical Evaluation of Florbetapir F 18 (18F-AV-45) Florbetapir F 18 - Alzheimer Disease, Mild Cognitive Impairment | Phase 2 | Completed | Avid Radiopharmaceuticals | 1768 | 2009-12-01 | 2018-07-18 |
| Imaging Characteristics of Florbetapir 18F in Patients With Frontotemporal Dementia, Alzheimer's Disease and Normal Controls. florbetapir 18F, 18F-FDG - Alzheimer's Disease, Frontotemporal Dementia | Phase 2 | Completed | Avid Radiopharmaceuticals | 34 | 2009-09-01 | 2014-09-29 |
| Ability Of ([18F]-AV-45) PET Scan to Distinguish Alzheimer's Disease Subjects From Cognitively Normal Individuals florbetapir F 18, [11C]-PIB - Alzheimer's Disease | Phase 2 | Completed | Avid Radiopharmaceuticals | 28 | 2009-03-01 | 2012-07-26 |
| Observational Study of Cognitive Outcomes for Subjects Who Have Had Prior PET Amyloid Imaging With Florbetapir F 18 (18F-AV-45) florbetapir F 18 - Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Completed | Avid Radiopharmaceuticals | 152 | 2009-01-01 | 2013-03-28 |
| Florbetapir F 18 PET Imaging of Beta-amyloid in Parkinson's Disease Patients florbetapir F 18 - Parkinson's Disease | Phase 2 | Completed | Avid Radiopharmaceuticals | 31 | 2009-01-01 | 2013-03-11 |
| A Phase II Trial of 18F-AV-45 Positron Emission Tomography (PET) Imaging in Healthy Volunteers, Patients With Mild Cognitive Impairment (MCI) and Patients With Alzheimer's Disease (AD) florbetapir F 18 - Alzheimer's Disease, Mild Cognitive Impairment | Phase 2 | Completed | Avid Radiopharmaceuticals | 184 | 2008-06-01 | 2012-05-10 |
Alzheimer Disease (8) · Cognitive Dysfunction (4) · Chronic Traumatic Encephalopathy (2) · Frontotemporal Dementia (1) · Neurodegenerative Diseases (1) · Parkinson Disease (1) · Pick Disease of the Brain (1) · Plaque, Amyloid (1)
Avid Radiopharmaceuticals (10) · Brigham and Women's Hospital (1)
United States (9) · Japan (1) · United Kingdom (1)
PMID 24716655, PMID 30969506, PMID 33587110
R43NS063607 (1)